CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research
Aug 01, 2017 12:00 pm UTC| Business
SANTA CLARA, Calif., Aug. 01, 2017 -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing...
Ensono Cloud Deploys NetApp SolidFire, Delivers Business-Critical IT Services
Aug 01, 2017 12:00 pm UTC| Business
SUNNYVALE, Calif., Aug. 01, 2017 -- “Ensono is committed to delivering a superior managed service experience to our clients. With NetApp® SolidFire®, our clients can focus on accelerating their businesses and leave the...
Enmotus Joins Dell/EMC’s Software and Peripherals (SnP) Program
Aug 01, 2017 11:55 am UTC| Business
ALISO VIEJO, Calif., Aug. 01, 2017 -- Enmotus, the market leader in Storage Automation and Analytics software (SAA), today announced that it has been added to the Dell/EMC Software and Peripherals program. Targeted for...
Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
Aug 01, 2017 11:50 am UTC| Business
Waltham, Mass., Aug. 01, 2017 -- Exosome Diagnostics, a leader in the liquid biopsy market, announced today that it has moved into a new worldwide headquarters and clinical laboratory in Waltham, MA. The state of the...
Aug 01, 2017 11:40 am UTC| Business
PLANTATION, Fla., Aug. 01, 2017 -- TradeStation, a Monex Group company and award-winning** online broker-dealer and futures commission merchant, announced today new pricing for futures for all new customers and all...
Affimed Reports Financial Results for Second Quarter 2017
Aug 01, 2017 11:31 am UTC| Business
Heidelberg, Germany, August 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...
Aug 01, 2017 11:30 am UTC| Business
Global Phase 3 Program Expected to Commence Before End of Q3 2017 International Phase 3 Trials Entitled “ULTIMATE I” and “ULTIMATE II” to be Led by Lawrence Steinman, MD, of Stanford University NEW YORK, Aug. 01, 2017...